what-when-how
In Depth Tutorials and Information
pathway, the reduced levels of secreted and processed
normal collagen give rise to an altered extracellular
matrix structure and component stoichiometry. This
altered extracellular matrix, in turn, fails to convey the
normal feedback signals that would promote differenti-
ation. For example, by analogy to the TSP-2 null mouse
(where the absence of thrombospondin led to increased
osteoblast proliferation and increased bone formation),
increased levels of thrombospondin in OI extracellu-
lar matrix may be associated with the decreased pro-
liferation and reduced amounts of bone being formed.
A number of transgenic knockouts of matrix compo-
nents have recently been described that share similar
phenotypes. 148-152 For example, the phenotype of the
osteonectin knockout 148 is reminiscent of the pheno-
type for the biglycan knockout 150 with a subtle presen-
tation and a phenotype more evident at older ages (an
aging but not a developmental phenotype). Defects
in the ratio and composition of matrix proteins in the
knockouts result in collagen fibril defects (osteonectin,
decorin and biglycan bind collagen) which could in
turn affect the cell. In OI, the levels of not only type I
collagen, but also other matrix components, are altered.
Thus, feedback from the extracellular matrix to the cell
could be drastically altered.
The feedback system could include disrupted growth
factor/cytokine sequestration in an OI altered extracellu-
lar matrix and subsequent deficient growth factor recep-
tor signaling. Normal receptor recognition of matrix
components and subsequent signal transduction may be
perturbed in OI. 43,45 An OI perturbed signaling pathway
might involve collagen interaction with alpha2beta1 inte-
grin that activates MAPK that then phosphorylates and
activates RUNX2. 153-155 Reduced type I collagen in the
matrix in OI would then lead to reduced RUNX2 acti-
vation and activity. The deficit in extracellular feedback
ultimately leads to a failure to alter specific transcrip-
tion factor expression and maintain the differentiation
program.
A second possible pathway involves a failure to accu-
mulate differentiated, mature osteoblasts because the
necessity of chronically diverting resources to the error
checking and editing machinery and stress responses
subverts cell survival. The cell must respond to a muta-
tion in its most abundant product. Error checking mech-
anisms in the cell include chaperone and/or protein
disulfide isomerase target binding and sequestration
in the endoplasmic reticulum as well as intracellular
(proteasomes) and extracellular (protease) degradation
of abnormal collagen. 156,157 Induction of an endoplas-
mic reticulum stress-specific unfolded protein response
involves upregulation of chaperones and caspases that
promote apoptosis. 158 Mature osteoblasts do not accumu-
late because they are more likely to undergo apoptosis in
response to chronic stress. Identifying and distinguishing
between these different pathways that translate the dis-
tinct genetic events to a molecular, cellular and physi-
ological phenotype provides a robust framework for
translational research in OI.
References
[1] Cundy T. Recent advances in osteogenesis imperfecta. Calcif
Tissue Int 2012;90(6):439-49.
[2] Long F. Building strong bones: molecular regulation of the
osteoblast lineage. Nat Rev Mol Cell Biol 2012;13(1):27-38.
[3] Westendorf JJ, Hiebert SW. Mammalian runt-domain proteins
and their roles in hematopoiesis, osteogenesis, and leukemia.
J Cell Biochem 1999(Suppl. 32-33):51-8.
[4] Komori T. Regulation of bone development and extracellular
matrix protein genes by RUNX2. Cell Tissue Res 2010;339(1):
189-95.
[5] Komori T. Signaling networks in RUNX2-dependent bone
development. J Cell Biochem 2011;112(3):750-5.
[6] Otto F, Kanegane H, Mundlos S. Mutations in the RUNX2
gene in patients with cleidocranial dysplasia. Hum Mutat
2002;19(3):209-16.
[7] Schroeder TM, Jensen ED, Westendorf JJ. Runx2: a master orga-
nizer of gene transcription in developing and maturing osteo-
blasts. Birth Defects Res. C Embryo Today 2005;75(3):213-25.
[8] Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM,
Behringer RR, et al. The novel zinc inger-containing transcrip-
tion factor osterix is required for osteoblast differentiation and
bone formation. Cell 2002;108(1):17-29.
[9] Zhou X, Zhang Z, Feng JQ, Dusevich VM, Sinha K, Zhang
H, et  al. Multiple functions of Osterix are required for bone
growth and homeostasis in postnatal mice. Proc Natl Acad Sci
USA 2010;107(29):12919-24.
[10] Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T,
Suda T. Smad1 and smad5 act downstream of intracellular sig-
nalings of BMP-2 that inhibits myogenic differentiation and
induces osteoblast differentiation in C2C12 myoblasts. Biochem
Biophys Res Commun 1997;238(2):574-80.
[11] Yuasa T, Kataoka H, Kinto N, Iwamoto M, Enomoto-Iwamoto
M, Iemura S, et  al. Sonic hedgehog is involved in osteoblast
differentiation by cooperating with BMP-2. J Cell Physiol 2002;
193(2):225-32.
[12] Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signal-
ing in mesenchymal progenitors controls osteoblast and chon-
drocyte differentiation during vertebrate skeletogenesis. Dev Cell
2005;8(5):739-50.
[13] Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F. Sequential
roles of Hedgehog and Wnt signaling in osteoblast develop-
ment. Development 2005;132(1):49-60.
[14] Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch
signaling pathways in osteoblast differentiation. J Cell Biochem
2011;112(12):3491-501.
[15] Takeuchi Y, Nakayama K, Matsumoto T. Differentiation and cell
surface expression of transforming growth factor-beta recep-
tors are regulated by interaction with matrix collagen in murine
osteoblastic cells. J Biol Chem 1996;271(7):3938-44.
[16] Knothe Tate ML, Adamson JR, Tami AE, Bauer TW. The osteo-
cyte. Int J Biochem Cell Biol 2004;36(1):1-8.
[17] Bonewald LF. The amazing osteocyte. J Bone Miner Res
2011;26(2):229-38.
[18] Noble BS. The osteocyte lineage. Arch Biochem Biophys
2008;473(2):106-11.
[19] Xiong J, O'Brien CA. Osteocyte RANKL: new insights into
the control of bone remodeling. J Bone Miner Res 2012;27(3):
499-505.
Search WWH ::




Custom Search